Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori, isolates from Japan

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 8, 2000, Pages 2214-2216

  Kato, Mototsugu ^a   Yamaoka, Yoshio ^b,c   Kim, Jae J ^b,e   Reddy, Rita ^b   Asaka, Masahiro ^a   Kashima, Kei ^c   Osato, Michael S ^b   El Zaatari, Fouad A K ^b   Graham, David Y ^b   Kwon, Dong H ^b,d  

^a HOKKAIDO UNIVERSITY   (Japan)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; HELICOBACTER PYLORI; JAPAN; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; METRONIDAZOLE; MIDDLE AGED;

EID: 0033929895     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.8.2214-2216.2000     Document Type: Article

References (18)

1. Adamek, R. J., S. Suerbaum, B. Pfaffenbach, and W. Opferkuch. 1998. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin - influence on treatment outcome. Am. J. Gastroenterol. 93:386-389.
2. Debets-Ossenkopp, Y. J., A. J. Herscheid, R. G. Pot, E. J. Kuipers, J. G. Kusters, and C. M. Vandenbroucke-Grauls. 1999. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovaftoxacin in The Netherlands. J. Antimicroh. Chemother. 43:511-515.
3. European Study Group on Antibiotic Susceptibility of Helicobacter pylori. 1992. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 11:777-781.
4. Glupczynski, Y., A. Burette, E. De Koster, J. F. Nyst, M. Deltenre, S. Cadranel, L. Bourdeaux, and D. De Vos. 1990. Metronidazole resistance in Helicobacter pylori. Lancet 335:976-977.
5. Graham, D. Y. 1997. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 113:1983-1991.
6. Graham, D. Y., and M. F. Go. 1993. Helicobacter pylori: current status. Gastroenterology 105:279-282.
7. Ling, T. K., A. F. Cheng, J. J. Sung, P. Y. Yiu, and S. S. Chung. 1996. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study. Helicobacter 1:57-61. (Erratum, 1:129.)
8. Megraud, F. 1998. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 115:1278-1282.
9. Megraud, F., N. Lehn, T. Lind, E. Bayerdorffer, C. O'Morain, R. Spiller, P. Unge, S. V. van Zanten, M. Wrangstadh, and C. F. Burman. 1999. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob. Agents Chemother. 43:2747-2752.
10. National Institutes of Health Consensus Conference. 1994. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272:65-69.
11. NCCLS. 1999. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. NCCLS, Wayne, Pa.
12. Osato, M. S., R. Reddy, and D. Y. Graham. 1999. Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. Int. J. Antimicrob. Agents 12:341-347.
13. Seppala, H., T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenius, K. Lager, and P. Huovinen. 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N. Engl. J. Med. 337:441-446.
14. Vakil, N., B. Hahn, and D. McSorley, 1998. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am. J. Gastroenterol. 93:1432-1435.
15. van Zwet, A. A., W. A. de Boer, P. M. Schneeberger, J. Weel, A. R. Jansz, and J. C. Thijs. 1996. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands. Eur. J. Clin. Microbiol. Infect. Dis. 15:861-864.
16. Vasquez, A., Y. Valdez, R. H. Gilman, J. J. McDonald, T. U. Westblom, D. Berg, H. Mayta, and V. Gutierrez. 1996. Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. The Gastrointestinal Physiology Working Group of Universidad Peruana Cayetano Heredia and the Johns Hopkins University. J. Clin. Microbiol. 34: 1232-1234.
17. Walsh, J. H., and W. L. Peterson. 1995. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N. Engl. J. Med. 333: 984-991.
18. Wolle, K., M. Nilius, A. Leodolter, W. A. Muller, P. Malfertheiner, and W. Konig. 1998. Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur. J. Clin. Microbiol. Infect. Dis. 17:519-521.